LynxsurfBio (LSB) is building a blood-based screening platform for dementia. With a akin handheld device akin to a glucometer connected to an AI analytics platform, LSB’s vision is to provide real-time clinical decision support based on an easy blood test of a person’s neurological health for early diagnosis and personalized treatment adaptation. We see the future where such accessible ‘glucometer’ for dementia can be integrated as part of the standard place of care flow in doctor’s offices, clinics, long term care facilities and local pharmacies.
Intellectual Property
Fundraising
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
